137 related articles for article (PubMed ID: 30404764)
21. Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer.
Schwartz GK; Bertino J; Kemeny N; Saltz L; Kelsen DK; Tong W; Welch M; Endres S; Dimery I
Anticancer Drugs; 2004 Mar; 15(3):219-27. PubMed ID: 15014354
[TBL] [Abstract][Full Text] [Related]
22. Raltitrexed (Tomudex) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: preliminary results from phase I clinical trials.
Schwartz GK; Harstrick A; González Barón M
Eur J Cancer; 1999 Mar; 35 Suppl 1():S9-13. PubMed ID: 10645208
[TBL] [Abstract][Full Text] [Related]
23. Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trial.
Comella P; De Vita F; Mancarella S; De Lucia L; Biglietto M; Casaretti R; Farris A; Ianniello GP; Lorusso V; Avallone A; Cartenì G; Leo SS; Catalano G; De Lena M; Comella G
Ann Oncol; 2000 Oct; 11(10):1323-33. PubMed ID: 11106123
[TBL] [Abstract][Full Text] [Related]
24. Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients.
Seitz JF; Bennouna J; Paillot B; Gamelin E; François E; Conroy T; Raoul JL; Becouarn Y; Bertheault-Cvitkovic F; Ychou M; Nasca S; Fandi A; Barthelemy P; Douillard JY
Ann Oncol; 2002 Jul; 13(7):1072-9. PubMed ID: 12176786
[TBL] [Abstract][Full Text] [Related]
25. Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine.
Chakrabarti S; Sara J; Lobo R; Eiring R; Finnes H; Mitchell J; Hartgers M; Okano A; Halfdanarson T; Grothey A
Clin Colorectal Cancer; 2019 Mar; 18(1):52-57. PubMed ID: 30396850
[TBL] [Abstract][Full Text] [Related]
26. Raltitrexed as a substitute for capecitabine in metastatic gastric cancer: a case report and literature review.
Ladak I; Preti B; Dias B; Breadner DA
Ann Transl Med; 2022 Dec; 10(23):1285. PubMed ID: 36618781
[TBL] [Abstract][Full Text] [Related]
27. Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas.
Gebbia V; Verderame F; Ferraù F; Bordonaro R; Callari A; Caruso M; Tirrito ML; Valenza R; Cicero G; Borsellino N; Tralongo P
Ann Oncol; 2006 Jun; 17 Suppl 7():vii60-5. PubMed ID: 16760296
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of raltitrexed combinations with uracil- tegafur or mitomycin C as salvage treatment in advanced colorectal cancer patients: a multicenter study of Anatolian Society of Medical Oncology (ASMO).
Bozkurt O; Karaca H; Ciltas A; Kaplan MA; Benekli M; Sevinc A; Demirci U; Eren T; Kodaz H; Isikdogan A; Ozkan M; Buyukberber S
Asian Pac J Cancer Prev; 2014; 15(4):1845-9. PubMed ID: 24641419
[TBL] [Abstract][Full Text] [Related]
29. Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study.
Osterlund P; Kinos S; Pfeiffer P; Salminen T; Kwakman JJM; Frödin JE; Shah CH; Sorbye H; Ristamäki R; Halonen P; Soveri LM; Heervä E; Ålgars A; Bärlund M; Hagman H; McDermott R; O'Reilly M; Röckert R; Liposits G; Kallio R; Flygare P; Teske AJ; van Werkhoven E; Punt CJA; Glimelius B
ESMO Open; 2022 Jun; 7(3):100427. PubMed ID: 35798468
[TBL] [Abstract][Full Text] [Related]
30. Phase I study of irinotecan and raltitrexed in patients with advanced gastrointestinal tract adenocarcinoma.
Ford HE; Cunningham D; Ross PJ; Rao S; Aherne GW; Benepal TS; Price T; Massey A; Vernillet L; Gruia G
Br J Cancer; 2000 Jul; 83(2):146-52. PubMed ID: 10901362
[TBL] [Abstract][Full Text] [Related]
31. Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy.
Tsavaris N; Kosmas C; Vadiaka M; Koufos C
BMC Cancer; 2002; 2():2. PubMed ID: 11860608
[TBL] [Abstract][Full Text] [Related]
32. Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.
Feliu J; Castañón C; Salud A; Mel JR; Escudero P; Pelegrín A; López-Gómez L; Ruiz M; González E; Juárez F; Lizón J; Castro J; González-Barón M;
Br J Cancer; 2005 Nov; 93(11):1230-5. PubMed ID: 16265344
[TBL] [Abstract][Full Text] [Related]
33. Multicenter phase II trial evaluating a three-weekly schedule of irinotecan plus raltitrexed in patients with 5-fluorouracil-refractory advanced colorectal cancer.
Aparicio J; Vicent JM; Maestu I; Garcerá S; Busquier I; Bosch C; Llorca C; Díaz R; Fernández-Martos C; Galán A
Ann Oncol; 2003 Jul; 14(7):1121-5. PubMed ID: 12853356
[TBL] [Abstract][Full Text] [Related]
34. Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapy.
Caponigro F; Avallone A; Budillon A; Comella P; Comella G
Anticancer Drugs; 2001 Jul; 12(6):489-97. PubMed ID: 11459994
[TBL] [Abstract][Full Text] [Related]
35. Oral versus intravenous fluoropyrimidines for colorectal cancer.
Chionh F; Lau D; Yeung Y; Price T; Tebbutt N
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564
[TBL] [Abstract][Full Text] [Related]
36. Phase I study of mitoxantrone, raltitrexed, levofolinic acid and 5-fluorouracil in advanced solid tumours.
Caponigro F; Avallone A; Rivellini F; Comella P; Ionna F; De Rosa V; Comella G
Cancer Chemother Pharmacol; 2001; 47(2):113-6. PubMed ID: 11269736
[TBL] [Abstract][Full Text] [Related]
37. A comparison between raltitrexed plus cisplatin and docetaxel plus cisplatin in concurrent chemoradiation for non-surgical esophageal squamous cell carcinoma.
Xia X; Liu Z; Cai B; Di X; Sun X; Ge X
Cancer Radiother; 2021 Feb; 25(1):39-44. PubMed ID: 33419607
[TBL] [Abstract][Full Text] [Related]
38. [Raltitrexed and oxaliplatin in colorectal cancer: in vitro and in vivo study of a synergistic cytostatic combination].
Schüll B; Scheithauer W
Acta Med Austriaca; 2002; 29(4):124-31. PubMed ID: 12424937
[TBL] [Abstract][Full Text] [Related]
39. Bevacizumab Combined with S-1 and Raltitrexed for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies: A Phase II Study.
Chen Y; Zhou YW; Cheng K; Li ZP; Luo DY; Qiu M; Li Q; Wang X; Shen YL; Cao D; Yang Y; Bi F; Liu JY; Gou HF
Oncologist; 2021 Aug; 26(8):e1320-e1326. PubMed ID: 33830591
[TBL] [Abstract][Full Text] [Related]
40. Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis.
Guo JH; Zhang HY; Gao S; Zhang PJ; Li XT; Chen H; Wang XD; Zhu X
World J Gastroenterol; 2017 Feb; 23(8):1406-1411. PubMed ID: 28293087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
